Invesaro

Stocks Health care DERM

NASDAQ · Health care

Journey Medical Corp (DERM)

Journey Medical Corp brought in $68.2M of revenue over the twelve months to June 30, 2026, up 20.9% from a year earlier. It posted a net loss of $6.1M. At June 30, 2026 it held $25.6M in cash against $25.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.

Revenue (last 12 months)
$68.2M
+20.9% year on year
Net margin
-9.0%

What Journey Medical Corp does

Journey Medical Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker DERM.

Revenue and profit by year

Revenue
FY21: $44.5M $44.5M FY21FY21: $63.1M $63.1M FY21FY22: $73.7M $73.7M FY22FY23: $79.2M $79.2M FY23FY24: $56.1M $56.1M FY24FY25: $61.9M $61.9M FY25
Net income
FY21: $5.3M $5.3M FY21FY21: -$44M -$44M FY21FY22: -$29.6M -$29.6M FY22FY23: -$3.9M -$3.9M FY23FY24: -$14.7M -$14.7M FY24FY25: -$11.4M -$11.4M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$61.9M-$8.2M-$11.4M-$0.47n/a
2024$56.1M-$13.7M-$14.7M-$0.72-$24.1M
2023$79.2M-$2.1M-$3.9M-$0.21$240K
2022$73.7M-$27.5M-$29.6M-$1.69-$33.5M
2021$63.1M-$34.9M-$44M-$4.32n/a
2021$44.5M$7.9M$5.3M$0.49n/a

Latest SEC filings

What Journey Medical Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 12, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. August 12, 2026
  3. July 31, 2026
  4. July 15, 2026
  5. June 26, 2026
  6. May 13, 2026
    Quarterly report 10-Q · period to March 31, 2026
  7. May 13, 2026
  8. April 30, 2026
  9. April 30, 2026
  10. April 30, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 2, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about DERM

What does Journey Medical Corp do?

Journey Medical Corp is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker DERM.

Is Journey Medical Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $6.1M on revenue of $68.2M.

How much revenue does Journey Medical Corp make?

Over the twelve months to June 30, 2026 Journey Medical Corp reported revenue of $68.2M. That is 20.9% more than a year earlier.

When did Journey Medical Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026.

Similar companies

Follow DERM

Get an email when Journey Medical Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow DERM: get an email when it files

Where the numbers come from

Financial figures are the values Journey Medical Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.